Ajay Tambralli

Ajay Tambralli

Rheumatology | Pediatric Rheumatology | Pediatrics

7500 Challis Rd
Entrance 1, Level 1
Brighton, MI 48116

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Endothelial cell-derived plasminogen activator inhibitor-1 potentiates thrombosis in antiphospholipid syndrome.

Endothelial cell-derived plasminogen activator inhibitor-1 potentiates thrombosis in antiphospholipid syndrome.

Journal: Journal of autoimmunity

Published: January 19, 2026

Neutrophils take center stage in VEXAS syndrome pathogenesis.

Neutrophils take center stage in VEXAS syndrome pathogenesis.

Journal: The Journal of clinical investigation

Published: November 03, 2025

Microvascular Endothelial Cells License APS Vasculopathy Through YAP1- and CCN2-Mediated Signaling.

Microvascular Endothelial Cells License APS Vasculopathy Through YAP1- and CCN2-Mediated Signaling.

Journal: Circulation

Published: August 29, 2025

Molecular Stratification of Antiphospholipid Syndrome Through Integrative Analysis of the Whole-Blood RNA Transcriptome.

Molecular Stratification of Antiphospholipid Syndrome Through Integrative Analysis of the Whole-Blood RNA Transcriptome.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: June 01, 2025

Acinetobacter Baumannii Secreted Protease CpaA Inhibits Factor XII-Mediated Bradykinin Generation and Neutrophil Activation.

Acinetobacter Baumannii Secreted Protease CpaA Inhibits Factor XII-Mediated Bradykinin Generation and Neutrophil Activation.

Journal: Circulation research

Published: May 13, 2025

Prothrombotic Activation of Platelet Pannexin-1 Channels in Antiphospholipid Syndrome.

Prothrombotic Activation of Platelet Pannexin-1 Channels in Antiphospholipid Syndrome.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: March 24, 2025

Prothrombotic Activation of Platelet Pannexin 1 Channels in Antiphospholipid Syndrome.

Prothrombotic Activation of Platelet Pannexin 1 Channels in Antiphospholipid Syndrome.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: March 24, 2025

Pediatric antiphospholipid syndrome: expanding our understanding of antiphospholipid syndrome in children.

Pediatric antiphospholipid syndrome: expanding our understanding of antiphospholipid syndrome in children.

Journal: Current opinion in rheumatology

Published: February 21, 2025

A disrupted adenosinergic axis facilitates platelet activation in APS: exploring a novel therapeutic target.

A disrupted adenosinergic axis facilitates platelet activation in APS: exploring a novel therapeutic target.

Journal: Blood advances

Published: February 11, 2025

Soluble CD13 is a potential mediator of neutrophil-induced thrombogenic inflammation in SARS-CoV-2 infection.

Soluble CD13 is a potential mediator of neutrophil-induced thrombogenic inflammation in SARS-CoV-2 infection.

Journal: JCI insight

Published: July 19, 2024

Inhibition of neutrophil extracellular trap formation alleviates vascular dysfunction in type 1 diabetic mice.

Inhibition of neutrophil extracellular trap formation alleviates vascular dysfunction in type 1 diabetic mice.

Journal: Science advances

Published: October 25, 2023

Low ectonucleotidase activity and increased neutrophil-platelet aggregates in patients with antiphospholipid syndrome.

Low ectonucleotidase activity and increased neutrophil-platelet aggregates in patients with antiphospholipid syndrome.

Journal: Blood

Published: August 07, 2023

Showing 1-12 of 21

Last Updated: 09/26/2026